150 related articles for article (PubMed ID: 26029453)
1. Surveillance for asymptomatic recurrence in resected stage III colon cancer: does it result in a more favorable outcome?
Smoragiewicz M; Lim H; Peixoto RD
J Gastrointest Oncol; 2015 Jun; 6(3):268-73. PubMed ID: 26029453
[TBL] [Abstract][Full Text] [Related]
2. Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer.
Samawi HH; Yin Y; Lim HJ; Cheung WY
J Gastrointest Cancer; 2018 Dec; 49(4):429-436. PubMed ID: 28674913
[TBL] [Abstract][Full Text] [Related]
3. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
[TBL] [Abstract][Full Text] [Related]
5. Palliative oxaliplatin-based chemotherapy after exposure to oxaliplatin in the adjuvant setting for colon cancer.
Peixoto RD; Kumar A; Lim HJ
J Gastrointest Oncol; 2015 Oct; 6(5):487-91. PubMed ID: 26487941
[TBL] [Abstract][Full Text] [Related]
6. Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapy.
De Dosso S; Nucifora M; Sahnane N; Epistolio S; Riveiro ME; Bertolini V; Bucci E; Boldorini R; Freguia S; Frattini M; Saletti P
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2994-3003. PubMed ID: 32271417
[TBL] [Abstract][Full Text] [Related]
7. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.
Peethambaram P; Weiss M; Loprinzi CL; Novotny P; O'Fallon JR; Erlichman C; O'Connell MJ; Laurie JA
Oncology; 1997; 54(4):287-92. PubMed ID: 9216852
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
[TBL] [Abstract][Full Text] [Related]
10. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
Jiang DM; Suzuki C; Espin-Garcia O; Lim CH; Ma LX; Sun P; Sim HW; Natori A; Chan BA; Moignard S; Chen EX; Liu G; Swallow CJ; Darling GE; Wong R; Jang RW; Elimova E
Cancer Med; 2020 May; 9(9):3023-3032. PubMed ID: 32130793
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Significance of Postoperative Adjuvant Chemotherapy in the Population Aged 75 Years and Older with Stage II-III Colorectal Cancer: A Retrospective Multi-Center Cohort Study.
Liu L; Pang X; Zhao K; Chen Y; Li Y; You R; Xu T; Liu M; Wu L; Li Z; Pu H
Int J Gen Med; 2023; 16():3311-3322. PubMed ID: 37554705
[TBL] [Abstract][Full Text] [Related]
12. Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.
Żok J; Bieńkowski M; Radecka B; Korniluk J; Adamowicz K; Duchnowska R
BMC Cancer; 2021 May; 21(1):529. PubMed ID: 33971834
[TBL] [Abstract][Full Text] [Related]
13. Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.
Petrelli F; Rulli E; Labianca R; Lonardi S; Rosati G; Dotti K; Ronzoni M; Pella N; Pusceddu V; Banzi M; Zampino MG; Yasmina M; Marchetti P; Cantore M; Zaniboni A; Rimassa L; Ciuffreda L; Ferrari D; Zagonel V; Maiello E; Sobrero A;
Ann Oncol; 2021 Jan; 32(1):66-76. PubMed ID: 33098997
[TBL] [Abstract][Full Text] [Related]
14. Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
Oncologist; 2022 Sep; 27(9):740-750. PubMed ID: 35648074
[TBL] [Abstract][Full Text] [Related]
15. Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
Chibaudel B; Henriques J; Rakez M; Brenner B; Kim TW; Martinez-Villacampa M; Gallego-Plazas J; Cervantes A; Shim K; Jonker D; Guerin-Meyer V; Mineur L; Banzi C; Dewdney A; Dejthevaporn T; Bloemendal HJ; Roth A; Moehler M; Aranda E; Van Cutsem E; Tabernero J; Schmoll HJ; Hoff PM; André T; de Gramont A
JAMA Netw Open; 2020 Oct; 3(10):e2020425. PubMed ID: 33074326
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy.
Udagawa S; Osumi H; Kozuki R; Ooki A; Wakatsuki T; Kurihara N; Mukai T; Yamaguchi T; Akiyoshi T; Fukunaga Y; Yamaguchi K; Shinozaki E
Surg Today; 2023 Dec; ():. PubMed ID: 38103076
[TBL] [Abstract][Full Text] [Related]
17. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?
Lechner P; Lind P; Goldenberg DM
J Am Coll Surg; 2000 Nov; 191(5):511-8. PubMed ID: 11085731
[TBL] [Abstract][Full Text] [Related]
18. Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer.
McMeekin DS; Tillmanns T; Chaudry T; Gold M; Johnson G; Walker J; Mannel R
Gynecol Oncol; 2004 Oct; 95(1):157-64. PubMed ID: 15385126
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
